By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
No open-market selling at Marimed Inc. in the past year, which is unusual. Instead two corporate insiders bought about $13,000 worth of MRMD.
Biggest single buyer: Shaw Timothy, COO, with roughly $5,000. Notably, at least one C-suite executive was among the buyers.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. 2 investment managers listed MRMD in their latest 13F filings (Q2 2026); more funds sold than bought.
Are insiders buying or selling MRMD stock?
In the last 12 months Marimed Inc. insiders made open-market purchases worth about $13,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in MRMD?
The most recent open-market insider trade in MRMD was filed on 2026-05-26.
How many institutions own MRMD?
2 investment managers reported holding MRMD in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded MRMD?
No congressional trades in MRMD were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).